Literature DB >> 15108364

Repression of the human immunodeficiency virus type-1 long terminal repeat by the c-Myc oncoprotein.

A Stojanova1, C Caro, R J V Jarjour, S K Oster, L Z Penn, R J Germinario.   

Abstract

The effect of trans-acting factors on cis-acting DNA elements on the HIV-1 promoter are the principal determinant regulating transcriptional activation and repression. Host factors that limit viral replication can contribute to the emergence and maintenance of proviral reservoirs. The current paradigm is that this sub-population of latently infected cells confers a biological advantage to the virus by facilitating evasion of immunologic responses and therapeutic strategies resulting in life-long and persistent infection. In this report, we show that ectopic expression of the nuclear phosphoprotein, c-Myc can inhibit HIV-1 gene expression and virus production in CD4+ T-lymphocytes. The effect exerted does not appear to involve other known functions of c-Myc such as proliferation, or apoptosis. The mechanism does implicate c-Myc in a direct role. We have found evidence that c-Myc can specifically recognize the HIV-1 initiator element surrounding the start site of transcription and linker scanning mutagenesis experiments confirmed a loss of c-Myc-mediated repression in the absence of this region. Moreover, we show that c-Myc can interact with the initiator binding proteins YY-1 and LBP-1 and can cooperate with these factors to synergistically repress HIV-1 LTR transcription. Taken together, these results indicate that c-Myc is an important regulator of HIV-1 transcription that potentially contributes to the latent proviral state. Copyright 2004 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15108364     DOI: 10.1002/jcb.20065

Source DB:  PubMed          Journal:  J Cell Biochem        ISSN: 0730-2312            Impact factor:   4.429


  10 in total

1.  c-Myc and Sp1 contribute to proviral latency by recruiting histone deacetylase 1 to the human immunodeficiency virus type 1 promoter.

Authors:  Guochun Jiang; Amy Espeseth; Daria J Hazuda; David M Margolis
Journal:  J Virol       Date:  2007-08-01       Impact factor: 5.103

2.  The neuronal host cell factor-binding protein Zhangfei inhibits herpes simplex virus replication.

Authors:  Oksana Akhova; Matthew Bainbridge; Vikram Misra
Journal:  J Virol       Date:  2005-12       Impact factor: 5.103

3.  HIV-1 reactivation induced by the periodontal pathogens Fusobacterium nucleatum and Porphyromonas gingivalis involves Toll-like receptor 2 [corrected] and 9 activation in monocytes/macrophages.

Authors:  Octavio A González; Mengtao Li; Jeffrey L Ebersole; Chifu B Huang
Journal:  Clin Vaccine Immunol       Date:  2010-07-07

Review 4.  Multiple Inhibitory Factors Act in the Late Phase of HIV-1 Replication: a Systematic Review of the Literature.

Authors:  Jean-François Gélinas; Deborah R Gill; Stephen C Hyde
Journal:  Microbiol Mol Biol Rev       Date:  2018-01-10       Impact factor: 11.056

Review 5.  Molecular control of HIV-1 postintegration latency: implications for the development of new therapeutic strategies.

Authors:  Laurence Colin; Carine Van Lint
Journal:  Retrovirology       Date:  2009-12-04       Impact factor: 4.602

6.  Selective targeting of the repressive transcription factors YY1 and cMyc to disrupt quiescent human immunodeficiency viruses.

Authors:  Kirston Barton; David Margolis
Journal:  AIDS Res Hum Retroviruses       Date:  2012-09-04       Impact factor: 2.205

Review 7.  Chromatin organization and virus gene expression.

Authors:  Paul M Lieberman
Journal:  J Cell Physiol       Date:  2008-08       Impact factor: 6.384

8.  Distinctive variation in the U3R region of the 5' Long Terminal Repeat from diverse HIV-1 strains.

Authors:  Christelle Mbondji-Wonje; Ming Dong; Xue Wang; Jiangqin Zhao; Viswanath Ragupathy; Ana M Sanchez; Thomas N Denny; Indira Hewlett
Journal:  PLoS One       Date:  2018-04-17       Impact factor: 3.240

9.  Control of stochastic gene expression by host factors at the HIV promoter.

Authors:  John C Burnett; Kathryn Miller-Jensen; Priya S Shah; Adam P Arkin; David V Schaffer
Journal:  PLoS Pathog       Date:  2009-01-09       Impact factor: 6.823

10.  CNS-specific regulatory elements in brain-derived HIV-1 strains affect responses to latency-reversing agents with implications for cure strategies.

Authors:  L R Gray; D Cowley; C Welsh; H K Lu; B J Brew; S R Lewin; S L Wesselingh; P R Gorry; M J Churchill
Journal:  Mol Psychiatry       Date:  2015-08-25       Impact factor: 15.992

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.